Redemption Price and Total Voting Rights

Bellevue Healthcare Trust PLC
01 December 2023
 

 

 

Bellevue Healthcare Trust plc (the "Company")

1 December 2023

Redemption Price and Total Voting Rights

The Company announced on 3 November 2023 that valid redemption requests in respect of 77,428,034 Ordinary Shares had been received for the 30 November 2023 Redemption Point.  All of these shares will be redeemed and cancelled by the Company.

The calculated Redemption Price is 142.07718 pence per share. All shareholders who validly applied to have their Ordinary Shares redeemed will receive this Redemption Price per share. It is expected that despatch of payments in respect of the valid redemption requests will be made on or around 14 December 2023.

Following this redemption, with effect from 30 November 2023, the issued share capital of the Company consists of 478,987,196 Ordinary Shares, of which 16,398,646 Ordinary Shares are held in Treasury. Therefore, the total number of voting rights in the Company is 462,588,550.

This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:                                                                                                                                                                                    

020 3327 9720

Company Secretary

Apex Listed Companies Services (UK) Limited

 

LEI: 213800HQ3J3H9YF2UI82

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings